EGFR blockade confers sensitivity to cabozantinib in hepatocellular carcinoma

Detalles Bibliográficos
Autores principales: Ma, Xuhui, Wu, Shanshan, Li, Botai, Zhang, Qianqian, Zhang, Jianming, Liu, Wenming, Yan, Hexin, Bernards, René, Qin, Wenxin, Wang, Cun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399229/
https://www.ncbi.nlm.nih.gov/pubmed/35999219
http://dx.doi.org/10.1038/s41421-022-00425-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399229/
https://www.ncbi.nlm.nih.gov/pubmed/35999219
http://dx.doi.org/10.1038/s41421-022-00425-y

Ejemplares similares